Santos Edson L, de Picoli Souza Kely, Cibrián-Uhalte Elena, Oliveira Suzana M, Bader Michael, Costa-Neto Claudio M, Oliveira Laerte, Pesquero João B
Department of Biophysics, Escola Paulista de Medicina, UNIFESP, São Paulo 04023-062, Brazil.
Int Immunopharmacol. 2008 Feb;8(2):282-8. doi: 10.1016/j.intimp.2007.09.007. Epub 2007 Oct 4.
In the kallikrein-kinin and renin-angiotensin systems the main receptors, B1 and B2 (kinin receptors) and AT1 and AT2 (angiotensin receptors) respectively, are seven-transmembrane domain G-protein-coupled receptors. Considering that the B1 agonists Des-Arg9-BK (Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe), Lys-desArg9-BK or Des-Arg10-KD (Lys-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe) and the AT1 agonist (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) have the same two residues at the C-terminal region (i.e. Pro-Phe), we hypothesized that TM V and TM VI of the B1 receptor could play an essential role in agonist binding and activity, being these regions receptor sites for binding the C-terminal sequences of Des-Arg-kinins similarly to that observed to AT1 receptor. To investigate this hypothesis, we replaced Arg212 for Ala at the top of the TM V and the sequence 274-282 (CPYHFFAFL) in TM VI of the rat kinin B1 receptor by the B2 receptor homologous sequence, 289-297 (FPFQISTFL) and subsequently analyzed the consequences of these mutations by competition binding and functional assays. Despite correct expression, observed at the mRNA and protein level by RT-PCR and confocal microscopy, respectively, no agonist binding and function was verified for the mutated receptors. Therefore, our results suggest an important role for Arg212 in the TM V and a region of TM VI of rat B1 receptor in the interaction with the C-terminal residues of Des-Arg-kinins, similar to that observed with AngII.
在激肽释放酶 - 激肽系统和肾素 - 血管紧张素系统中,主要受体分别为B1和B2(激肽受体)以及AT1和AT2(血管紧张素受体),它们是七跨膜结构域的G蛋白偶联受体。鉴于B1激动剂去精氨酸9 - 缓激肽(Arg - Pro - Pro - Gly - Phe - Ser - Pro - Phe)、赖氨酸 - 去精氨酸9 - 缓激肽或去精氨酸10 - KD(Lys - Arg - Pro - Pro - Gly - Phe - Ser - Pro - Phe)以及AT1激动剂(Asp - Arg - Val - Tyr - Ile - His - Pro - Phe)在C末端区域具有相同的两个残基(即Pro - Phe),我们推测B1受体的跨膜区V和跨膜区VI在激动剂结合和活性中可能起关键作用,这些区域是结合去精氨酸激肽C末端序列的受体位点,类似于在AT1受体中观察到的情况。为了研究这一假设,我们将大鼠激肽B1受体跨膜区V顶部的Arg212替换为Ala,并将跨膜区VI中的序列274 - 282(CPYHFFAFL)替换为B2受体的同源序列289 - 297(FPFQISTFL),随后通过竞争结合和功能测定分析这些突变的后果。尽管通过RT - PCR和共聚焦显微镜分别在mRNA和蛋白质水平观察到了正确表达,但未检测到突变受体的激动剂结合和功能。因此,我们的结果表明,大鼠B1受体跨膜区V中的Arg212以及跨膜区VI的一个区域在与去精氨酸激肽的C末端残基相互作用中起重要作用,类似于在血管紧张素II中观察到的情况。